Investigating muscle disease and treatment strategies at the University of Washington.
UW Center for Translational Muscle Research
The University of Washington's Center for Translational Muscle Research is working with experts to find new ways to treat muscle diseases and improve health as we age, so that patients can benefit from the latest discoveries and treatments.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11074562 on NIH RePORTER |
What this research studies
The University of Washington's Center for Translational Muscle Research focuses on enhancing research productivity related to muscle diseases and aging. This initiative brings together experts from various fields, including muscle disease, exercise, and neuromuscular plasticity, to develop innovative treatment strategies. The center provides essential resources, training, and funding opportunities to support new and ongoing research projects. By facilitating collaboration and offering advanced research tools, the center aims to translate findings into clinical applications that can benefit patients.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include children and adults with muscle diseases or age-related muscle conditions.
Not a fit: Patients with non-muscle related conditions or those outside the age range of 0-11 years may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies and improved treatment options for individuals suffering from muscle diseases.
How similar studies have performed: Previous research in muscle disease and aging has shown promising results, indicating that this approach has the potential for significant advancements.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Regnier, Michael — University of Washington
- Study coordinator: Regnier, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.